Enterprise Value
-4.611M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
3.40%
Insider Ownership
6.22%
Institutional Own.
1.25%
Qtr Updated
03/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GEN-011 Details Solid tumor/s, Cancer | Failed Discontinued | |
GEN-009 Details Solid tumor/s, Cancer | Failed Discontinued |